<br />
Issue 3 July 2011<br />
Drug Delivery<br />
Better Medicine<br />
From needle-free to nanotechnology, new drug delivery<br />
systems are set to revolutionise medical treatment<br />
Pharma<br />
Technology Focus<br />
IN THIS ISSUE<br />
Goodbye to daily injections?<br />
Spotlight on the oral drugs market<br />
Risk vs revenue: combination drugs<br />
Contents<br />
Issue #3 July 2011<br />
A New Era for Drug Delivery<br />
Drug delivery technologies are coming of age<br />
and attracting major investment<br />
Special Delivery<br />
We examine the driving factors for future<br />
growth in the global drug delivery market<br />
Money Where the Mouth Is<br />
The oral drugs sector is expected to continue its<br />
next five years<br />
ctions?<br />
systems could open<br />
ering medication<br />
emerging as a key<br />
petitive market<br />
me the challenges of<br />
to market<br />
Drug Delivery<br />
Ph<a title="Drug Delivery | Issue #3 | July 2011 page 1" href="https://secure.viewer.zmags.com/publication/a155b56a?page=1"> Issue 3 July 2011 Drug Delivery </a>
<a title="Drug Delivery | Issue #3 | July 2011 page 2" href="https://secure.viewer.zmags.com/publication/a155b56a?page=2"> Contents Issue #3 July 2011 A New E</a>
<a title="Drug Delivery | Issue #3 | July 2011 page 3" href="https://secure.viewer.zmags.com/publication/a155b56a?page=3"> ULTRA-TURRAX® Tube Drive control World‘s first:</a>
<a title="Drug Delivery | Issue #3 | July 2011 page 4" href="https://secure.viewer.zmags.com/publication/a155b56a?page=4"> Industry News Navigation: Select a news catego</a>
<a title="Drug Delivery | Issue #3 | July 2011 page 5" href="https://secure.viewer.zmags.com/publication/a155b56a?page=5"> Companies and academic institutions worldwide are</a>
<a title="Drug Delivery | Issue #3 | July 2011 page 6" href="https://secure.viewer.zmags.com/publication/a155b56a?page=6"> Drug delivery technologies are coming of age and </a>
<a title="Drug Delivery | Issue #3 | July 2011 page 7" href="https://secure.viewer.zmags.com/publication/a155b56a?page=7"> MUCH INVESTMENT WILL CONTINUE TO BE DIRECTED TOWA</a>
<a title="Drug Delivery | Issue #3 | July 2011 page 8" href="https://secure.viewer.zmags.com/publication/a155b56a?page=8"> An Unparalleled Global Face-2-Face</a>
<a title="Drug Delivery | Issue #3 | July 2011 page 9" href="https://secure.viewer.zmags.com/publication/a155b56a?page=9"> Special Delivery As the pharmaceutical industry </a>
<a title="Drug Delivery | Issue #3 | July 2011 page 10" href="https://secure.viewer.zmags.com/publication/a155b56a?page=10"> </a>
<a title="Drug Delivery | Issue #3 | July 2011 page 11" href="https://secure.viewer.zmags.com/publication/a155b56a?page=11"> We have a challenging and inspiring mission: To i</a>
<a title="Drug Delivery | Issue #3 | July 2011 page 12" href="https://secure.viewer.zmags.com/publication/a155b56a?page=12"> Accounting for more than half of the dru</a>
<a title="Drug Delivery | Issue #3 | July 2011 page 13" href="https://secure.viewer.zmags.com/publication/a155b56a?page=13"> The drug delivery market is gradually becoming an</a>
<a title="Drug Delivery | Issue #3 | July 2011 page 14" href="https://secure.viewer.zmags.com/publication/a155b56a?page=14"> A focus on paediatric and geriatric markets has f</a>
<a title="Drug Delivery | Issue #3 | July 2011 page 15" href="https://secure.viewer.zmags.com/publication/a155b56a?page=15"> Encap Drug Delivery Global Experts in Oral Drug D</a>
<a title="Drug Delivery | Issue #3 | July 2011 page 16" href="https://secure.viewer.zmags.com/publication/a155b56a?page=16"> GOODBYE TO DAILY INJECTIONS? Research suggests th</a>
<a title="Drug Delivery | Issue #3 | July 2011 page 17" href="https://secure.viewer.zmags.com/publication/a155b56a?page=17"> “ THE USE OF DRUG DELIVERY SYSTEMS IS OFTEN A </a>
<a title="Drug Delivery | Issue #3 | July 2011 page 18" href="https://secure.viewer.zmags.com/publication/a155b56a?page=18"> The Bio-Images Group provides in</a>
<a title="Drug Delivery | Issue #3 | July 2011 page 19" href="https://secure.viewer.zmags.com/publication/a155b56a?page=19"> MUTUALLY BENEFICIAL LIKE MOST BUSINESSES AROUND T</a>
<a title="Drug Delivery | Issue #3 | July 2011 page 20" href="https://secure.viewer.zmags.com/publication/a155b56a?page=20"> Faced with a host of market challenges, such as d</a>
<a title="Drug Delivery | Issue #3 | July 2011 page 21" href="https://secure.viewer.zmags.com/publication/a155b56a?page=21"> Drug Delivery Devices </a>
<a title="Drug Delivery | Issue #3 | July 2011 page 22" href="https://secure.viewer.zmags.com/publication/a155b56a?page=22"> i RiskyBus Developing combination drugs and bring</a>
<a title="Drug Delivery | Issue #3 | July 2011 page 23" href="https://secure.viewer.zmags.com/publication/a155b56a?page=23"> “ Many biologic products are high- </a>
<a title="Drug Delivery | Issue #3 | July 2011 page 24" href="https://secure.viewer.zmags.com/publication/a155b56a?page=24"> Pharma Technology Focus Editorial Duncan West </a>
<a title="Drug Delivery | Issue #3 | July 2011 page 25" href="https://secure.viewer.zmags.com/publication/a155b56a?page=25"> 2nd Annual KEY REASONS TO ATTEND: Explo</a>